Mario Adami

Mario Adami is an experienced finance professional currently serving as the Head of Finance for R&D and Corporate Functions at Galderma since March 2022. Prior roles include Finance Director at Takeda, overseeing GPLS Neuroscience and Gastrointestinal, and PVPS Rare Metabolic Disease, as well as Head of Finance for multiple franchises at Shire. Mario's tenure at Novartis spanned from 2000 to 2018, during which key positions included Global Program Finance Unit Head for Oncology and roles across various departments related to finance management. Mario holds a Master of Science in Wirtschaftswissenschaften from the University of Basel and has further education from Harvard Business School and The Wharton School.